Los Angeles Capital Management LLC Has $4.55 Million Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Los Angeles Capital Management LLC lifted its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 92.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,597 shares of the company's stock after acquiring an additional 26,690 shares during the quarter. Los Angeles Capital Management LLC owned 0.06% of HealthEquity worth $4,551,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Truist Financial Corp grew its stake in HealthEquity by 7.0% in the second quarter. Truist Financial Corp now owns 2,864 shares of the company's stock valued at $247,000 after purchasing an additional 188 shares during the last quarter. O Shaughnessy Asset Management LLC grew its stake in HealthEquity by 3.9% in the first quarter. O Shaughnessy Asset Management LLC now owns 5,219 shares of the company's stock valued at $426,000 after purchasing an additional 197 shares during the last quarter. Nisa Investment Advisors LLC grew its stake in HealthEquity by 7.5% in the second quarter. Nisa Investment Advisors LLC now owns 2,854 shares of the company's stock valued at $246,000 after purchasing an additional 198 shares during the last quarter. Elk River Wealth Management LLC grew its stake in HealthEquity by 0.3% in the third quarter. Elk River Wealth Management LLC now owns 66,181 shares of the company's stock valued at $5,417,000 after purchasing an additional 217 shares during the last quarter. Finally, CWM LLC grew its stake in shares of HealthEquity by 6.9% during the second quarter. CWM LLC now owns 3,958 shares of the company's stock worth $341,000 after acquiring an additional 255 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. JMP Securities reiterated a "market outperform" rating and issued a $105.00 price target on shares of HealthEquity in a report on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of HealthEquity from $102.00 to $103.00 and gave the company a "buy" rating in a report on Wednesday, September 4th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $92.00 target price on shares of HealthEquity in a research report on Wednesday, September 4th. Barrington Research reaffirmed an "outperform" rating and issued a $105.00 target price on shares of HealthEquity in a research report on Friday, September 20th. Finally, Bank of America dropped their target price on HealthEquity from $105.00 to $100.00 and set a "buy" rating for the company in a research report on Wednesday, September 4th. Twelve analysts have rated the stock with a buy rating, According to MarketBeat, HealthEquity currently has a consensus rating of "Buy" and an average target price of $103.83.

Insider Buying and Selling

In other news, Director Frank Corvino sold 1,039 shares of the firm's stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total value of $99,847.90. Following the transaction, the director now directly owns 3,784 shares in the company, valued at $363,642.40. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other HealthEquity news, Director Frank Corvino sold 1,039 shares of the business's stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total transaction of $99,847.90. Following the completion of the transaction, the director now directly owns 3,784 shares of the company's stock, valued at $363,642.40. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of the stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the sale, the director now directly owns 54,719 shares of the company's stock, valued at approximately $4,540,582.62. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 10,536 shares of company stock worth $884,517. 2.20% of the stock is owned by company insiders.

HealthEquity Stock Performance

Shares of HealthEquity stock traded up $0.43 during trading hours on Tuesday, hitting $100.70. 138,052 shares of the company were exchanged, compared to its average volume of 613,301. HealthEquity, Inc. has a 1 year low of $62.10 and a 1 year high of $101.17. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. The business has a 50-day moving average of $83.57 and a 200-day moving average of $80.60. The stock has a market capitalization of $8.79 billion, a price-to-earnings ratio of 83.56, a P/E/G ratio of 1.55 and a beta of 0.52.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, topping the consensus estimate of $0.50 by $0.16. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. The business had revenue of $299.93 million during the quarter, compared to analysts' expectations of $284.48 million. As a group, analysts expect that HealthEquity, Inc. will post 2.27 EPS for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.